Review



deoxy d glucose  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    MedChemExpress deoxy d glucose
    Deoxy D Glucose, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 497 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d-glucose/2-Deoxy-D-glucose/pm42595780-48-62-65
    Average 99 stars, based on 497 article reviews
    deoxy d glucose - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: SnRNA-seq and genome-wide CRISPR screening define the complete transcriptional trajectory and functional drivers of podocyte stress.
    Article Snippet: n, cells were AR TIC LE IN PR ES S transferred to 37 °C and cultured for 10 days before subsequent experiments. Differentiated podocytes were exposed to eight commonly used injury stimuli: ADR (0.4μM; MCE, HY-15142)48, ANG II (100ng/ml; MCE, HY-P7028)48, glucose (30mmol/L; MCE, HY-B0389)49, IL-1β (50 ng/ml; MCE, HY-P7028)50, LPS (25 μg/ml; MCE, HY-D1056)51, PA (750 μM; MCE, HY-N0830)52, TGF-β (5 ng

    Flow Cytometry:

    Article Title: SnRNA-seq and genome-wide CRISPR screening define the complete transcriptional trajectory and functional drivers of podocyte stress.
    Article Snippet: n, cells were AR TIC LE IN PR ES S transferred to 37 °C and cultured for 10 days before subsequent experiments. Differentiated podocytes were exposed to eight commonly used injury stimuli: ADR (0.4μM; MCE, HY-15142)48, ANG II (100ng/ml; MCE, HY-P7028)48, glucose (30mmol/L; MCE, HY-B0389)49, IL-1β (50 ng/ml; MCE, HY-P7028)50, LPS (25 μg/ml; MCE, HY-D1056)51, PA (750 μM; MCE, HY-N0830)52, TGF-β (5 ng

    Cytometry:

    Article Title: SnRNA-seq and genome-wide CRISPR screening define the complete transcriptional trajectory and functional drivers of podocyte stress.
    Article Snippet: n, cells were AR TIC LE IN PR ES S transferred to 37 °C and cultured for 10 days before subsequent experiments. Differentiated podocytes were exposed to eight commonly used injury stimuli: ADR (0.4μM; MCE, HY-15142)48, ANG II (100ng/ml; MCE, HY-P7028)48, glucose (30mmol/L; MCE, HY-B0389)49, IL-1β (50 ng/ml; MCE, HY-P7028)50, LPS (25 μg/ml; MCE, HY-D1056)51, PA (750 μM; MCE, HY-N0830)52, TGF-β (5 ng

    Synthesized:

    Article Title: SnRNA-seq and genome-wide CRISPR screening define the complete transcriptional trajectory and functional drivers of podocyte stress.
    Article Snippet: n, cells were AR TIC LE IN PR ES S transferred to 37 °C and cultured for 10 days before subsequent experiments. Differentiated podocytes were exposed to eight commonly used injury stimuli: ADR (0.4μM; MCE, HY-15142)48, ANG II (100ng/ml; MCE, HY-P7028)48, glucose (30mmol/L; MCE, HY-B0389)49, IL-1β (50 ng/ml; MCE, HY-P7028)50, LPS (25 μg/ml; MCE, HY-D1056)51, PA (750 μM; MCE, HY-N0830)52, TGF-β (5 ng

    Plasmid Preparation:

    Article Title: SnRNA-seq and genome-wide CRISPR screening define the complete transcriptional trajectory and functional drivers of podocyte stress.
    Article Snippet: n, cells were AR TIC LE IN PR ES S transferred to 37 °C and cultured for 10 days before subsequent experiments. Differentiated podocytes were exposed to eight commonly used injury stimuli: ADR (0.4μM; MCE, HY-15142)48, ANG II (100ng/ml; MCE, HY-P7028)48, glucose (30mmol/L; MCE, HY-B0389)49, IL-1β (50 ng/ml; MCE, HY-P7028)50, LPS (25 μg/ml; MCE, HY-D1056)51, PA (750 μM; MCE, HY-N0830)52, TGF-β (5 ng

    shRNA:

    Article Title: SnRNA-seq and genome-wide CRISPR screening define the complete transcriptional trajectory and functional drivers of podocyte stress.
    Article Snippet: n, cells were AR TIC LE IN PR ES S transferred to 37 °C and cultured for 10 days before subsequent experiments. Differentiated podocytes were exposed to eight commonly used injury stimuli: ADR (0.4μM; MCE, HY-15142)48, ANG II (100ng/ml; MCE, HY-P7028)48, glucose (30mmol/L; MCE, HY-B0389)49, IL-1β (50 ng/ml; MCE, HY-P7028)50, LPS (25 μg/ml; MCE, HY-D1056)51, PA (750 μM; MCE, HY-N0830)52, TGF-β (5 ng

    Stable Transfection:

    Article Title: SnRNA-seq and genome-wide CRISPR screening define the complete transcriptional trajectory and functional drivers of podocyte stress.
    Article Snippet: n, cells were AR TIC LE IN PR ES S transferred to 37 °C and cultured for 10 days before subsequent experiments. Differentiated podocytes were exposed to eight commonly used injury stimuli: ADR (0.4μM; MCE, HY-15142)48, ANG II (100ng/ml; MCE, HY-P7028)48, glucose (30mmol/L; MCE, HY-B0389)49, IL-1β (50 ng/ml; MCE, HY-P7028)50, LPS (25 μg/ml; MCE, HY-D1056)51, PA (750 μM; MCE, HY-N0830)52, TGF-β (5 ng

    Control:

    Article Title: SnRNA-seq and genome-wide CRISPR screening define the complete transcriptional trajectory and functional drivers of podocyte stress.
    Article Snippet: n, cells were AR TIC LE IN PR ES S transferred to 37 °C and cultured for 10 days before subsequent experiments. Differentiated podocytes were exposed to eight commonly used injury stimuli: ADR (0.4μM; MCE, HY-15142)48, ANG II (100ng/ml; MCE, HY-P7028)48, glucose (30mmol/L; MCE, HY-B0389)49, IL-1β (50 ng/ml; MCE, HY-P7028)50, LPS (25 μg/ml; MCE, HY-D1056)51, PA (750 μM; MCE, HY-N0830)52, TGF-β (5 ng

    Transfection:

    Article Title: SnRNA-seq and genome-wide CRISPR screening define the complete transcriptional trajectory and functional drivers of podocyte stress.
    Article Snippet: n, cells were AR TIC LE IN PR ES S transferred to 37 °C and cultured for 10 days before subsequent experiments. Differentiated podocytes were exposed to eight commonly used injury stimuli: ADR (0.4μM; MCE, HY-15142)48, ANG II (100ng/ml; MCE, HY-P7028)48, glucose (30mmol/L; MCE, HY-B0389)49, IL-1β (50 ng/ml; MCE, HY-P7028)50, LPS (25 μg/ml; MCE, HY-D1056)51, PA (750 μM; MCE, HY-N0830)52, TGF-β (5 ng

    Negative Control:

    Article Title: SnRNA-seq and genome-wide CRISPR screening define the complete transcriptional trajectory and functional drivers of podocyte stress.
    Article Snippet: n, cells were AR TIC LE IN PR ES S transferred to 37 °C and cultured for 10 days before subsequent experiments. Differentiated podocytes were exposed to eight commonly used injury stimuli: ADR (0.4μM; MCE, HY-15142)48, ANG II (100ng/ml; MCE, HY-P7028)48, glucose (30mmol/L; MCE, HY-B0389)49, IL-1β (50 ng/ml; MCE, HY-P7028)50, LPS (25 μg/ml; MCE, HY-D1056)51, PA (750 μM; MCE, HY-N0830)52, TGF-β (5 ng

    Recombinant:

    Article Title: SnRNA-seq and genome-wide CRISPR screening define the complete transcriptional trajectory and functional drivers of podocyte stress.
    Article Snippet: n, cells were AR TIC LE IN PR ES S transferred to 37 °C and cultured for 10 days before subsequent experiments. Differentiated podocytes were exposed to eight commonly used injury stimuli: ADR (0.4μM; MCE, HY-15142)48, ANG II (100ng/ml; MCE, HY-P7028)48, glucose (30mmol/L; MCE, HY-B0389)49, IL-1β (50 ng/ml; MCE, HY-P7028)50, LPS (25 μg/ml; MCE, HY-D1056)51, PA (750 μM; MCE, HY-N0830)52, TGF-β (5 ng



    Similar Products

    99
    MedChemExpress deoxy d glucose
    Deoxy D Glucose, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d-glucose/2-Deoxy-D-glucose/pm42595780-48-62-65
    Average 99 stars, based on 1 article reviews
    deoxy d glucose - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    Thermo Fisher high glucose
    High Glucose, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d-glucose/D(%2B)-Glucose/pmc12811471-83-16-24
    Average 99 stars, based on 1 article reviews
    high glucose - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    92
    Valiant Co Ltd d glucose solution
    D Glucose Solution, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d-glucose/D-(%2B)-Dextrose/pmc12816905-85-27-29
    Average 92 stars, based on 1 article reviews
    d glucose solution - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    86
    Sangon Biotech d glucose
    D Glucose, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d-glucose/d+glucose/pmc12856427-99-16-40
    Average 86 stars, based on 1 article reviews
    d glucose - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    98
    Thermo Fisher d glucose
    D Glucose, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d-glucose/D-(%2B)-Glucose%2C+1M+aq%2E+soln%2E%2C+sterile-filtered/pmc13315006-197-22-23
    Average 98 stars, based on 1 article reviews
    d glucose - by Bioz Stars, 2026-09
    98/100 stars
      Buy from Supplier

    99
    MedChemExpress 2-deoxy-d-glucose
    2 Deoxy D Glucose, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d-glucose/2-Deoxy-D-glucose/custom%40hy-13966%4042551179
    Average 99 stars, based on 1 article reviews
    2-deoxy-d-glucose - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress mce cat
    Mce Cat, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d-glucose/2-Deoxy-D-glucose/pm42519827-286-217-217
    Average 99 stars, based on 1 article reviews
    mce cat - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress sur 2 dg mice
    The target genes regulated by H3K18la were identified by CUT&Tag assay combined with RNA‐seq. (A) Average plot and heat map displaying the binding density of H3K18la with different H3K18la binding peaks in hippocampus of the Sur group and Con group. (B) Genome‐wide distribution of the upregulated H3K18la‐binding peaks in mice after surgery. (C) Bar graph illustrating the number of target genes associated with upregulated and downregulated H3K18la peaks, and the top 2 enriched de novo motifs of target genes. (D) GO analysis of candidate target genes associated with upregulated H3K18la peaks. (E) Volcano plot of differentially expressed genes in RNA‐seq ( n = 3). (F) Heat map showing TOP 20 differential genes <t>after</t> <t>2‐DG</t> treatment in RNA‐seq ( n = 3). (G) Venn diagram showing the intersection of H3K18la up‐regulated target genes and 2‐DG down‐regulated target genes. (H) Genome browser tracks show H3K18la binding at representative target gene loci. Peaks specifically located at the Lag3 promoters are identified by red rectangles. (I) H3K18la occupancy analysis by ChIP‐qPCR ( n = 3). Data are mean ± SD. Statistical significance was assessed by unpaired 2‐tailed Student t ‐test compared with Con group. **** p < 0.0001.
    Sur 2 Dg Mice, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d-glucose/2-Deoxy-D-glucose/pmc13403156-56-0-8
    Average 99 stars, based on 1 article reviews
    sur 2 dg mice - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    96
    MedChemExpress d-glucose
    The target genes regulated by H3K18la were identified by CUT&Tag assay combined with RNA‐seq. (A) Average plot and heat map displaying the binding density of H3K18la with different H3K18la binding peaks in hippocampus of the Sur group and Con group. (B) Genome‐wide distribution of the upregulated H3K18la‐binding peaks in mice after surgery. (C) Bar graph illustrating the number of target genes associated with upregulated and downregulated H3K18la peaks, and the top 2 enriched de novo motifs of target genes. (D) GO analysis of candidate target genes associated with upregulated H3K18la peaks. (E) Volcano plot of differentially expressed genes in RNA‐seq ( n = 3). (F) Heat map showing TOP 20 differential genes <t>after</t> <t>2‐DG</t> treatment in RNA‐seq ( n = 3). (G) Venn diagram showing the intersection of H3K18la up‐regulated target genes and 2‐DG down‐regulated target genes. (H) Genome browser tracks show H3K18la binding at representative target gene loci. Peaks specifically located at the Lag3 promoters are identified by red rectangles. (I) H3K18la occupancy analysis by ChIP‐qPCR ( n = 3). Data are mean ± SD. Statistical significance was assessed by unpaired 2‐tailed Student t ‐test compared with Con group. **** p < 0.0001.
    D Glucose, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d-glucose/D-Glucose/custom%40hy-b0389%4042498920
    Average 96 stars, based on 1 article reviews
    d-glucose - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    99
    MedChemExpress glycolysis inhibitor 2 deoxy d glucose
    The target genes regulated by H3K18la were identified by CUT&Tag assay combined with RNA‐seq. (A) Average plot and heat map displaying the binding density of H3K18la with different H3K18la binding peaks in hippocampus of the Sur group and Con group. (B) Genome‐wide distribution of the upregulated H3K18la‐binding peaks in mice after surgery. (C) Bar graph illustrating the number of target genes associated with upregulated and downregulated H3K18la peaks, and the top 2 enriched de novo motifs of target genes. (D) GO analysis of candidate target genes associated with upregulated H3K18la peaks. (E) Volcano plot of differentially expressed genes in RNA‐seq ( n = 3). (F) Heat map showing TOP 20 differential genes <t>after</t> <t>2‐DG</t> treatment in RNA‐seq ( n = 3). (G) Venn diagram showing the intersection of H3K18la up‐regulated target genes and 2‐DG down‐regulated target genes. (H) Genome browser tracks show H3K18la binding at representative target gene loci. Peaks specifically located at the Lag3 promoters are identified by red rectangles. (I) H3K18la occupancy analysis by ChIP‐qPCR ( n = 3). Data are mean ± SD. Statistical significance was assessed by unpaired 2‐tailed Student t ‐test compared with Con group. **** p < 0.0001.
    Glycolysis Inhibitor 2 Deoxy D Glucose, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/d-glucose/2-Deoxy-D-glucose/pm42470959-110-16-31
    Average 99 stars, based on 1 article reviews
    glycolysis inhibitor 2 deoxy d glucose - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    The target genes regulated by H3K18la were identified by CUT&Tag assay combined with RNA‐seq. (A) Average plot and heat map displaying the binding density of H3K18la with different H3K18la binding peaks in hippocampus of the Sur group and Con group. (B) Genome‐wide distribution of the upregulated H3K18la‐binding peaks in mice after surgery. (C) Bar graph illustrating the number of target genes associated with upregulated and downregulated H3K18la peaks, and the top 2 enriched de novo motifs of target genes. (D) GO analysis of candidate target genes associated with upregulated H3K18la peaks. (E) Volcano plot of differentially expressed genes in RNA‐seq ( n = 3). (F) Heat map showing TOP 20 differential genes after 2‐DG treatment in RNA‐seq ( n = 3). (G) Venn diagram showing the intersection of H3K18la up‐regulated target genes and 2‐DG down‐regulated target genes. (H) Genome browser tracks show H3K18la binding at representative target gene loci. Peaks specifically located at the Lag3 promoters are identified by red rectangles. (I) H3K18la occupancy analysis by ChIP‐qPCR ( n = 3). Data are mean ± SD. Statistical significance was assessed by unpaired 2‐tailed Student t ‐test compared with Con group. **** p < 0.0001.

    Journal: CNS Neuroscience & Therapeutics

    Article Title: Histone H3K18 Lactylation Contributes to Perioperative Neurocognitive Disorder Through Immune Checkpoint Lymphocyte Activation Gene 3 Mediated Microglial Pyroptosis

    doi: 10.1002/cns.71058

    Figure Lengend Snippet: The target genes regulated by H3K18la were identified by CUT&Tag assay combined with RNA‐seq. (A) Average plot and heat map displaying the binding density of H3K18la with different H3K18la binding peaks in hippocampus of the Sur group and Con group. (B) Genome‐wide distribution of the upregulated H3K18la‐binding peaks in mice after surgery. (C) Bar graph illustrating the number of target genes associated with upregulated and downregulated H3K18la peaks, and the top 2 enriched de novo motifs of target genes. (D) GO analysis of candidate target genes associated with upregulated H3K18la peaks. (E) Volcano plot of differentially expressed genes in RNA‐seq ( n = 3). (F) Heat map showing TOP 20 differential genes after 2‐DG treatment in RNA‐seq ( n = 3). (G) Venn diagram showing the intersection of H3K18la up‐regulated target genes and 2‐DG down‐regulated target genes. (H) Genome browser tracks show H3K18la binding at representative target gene loci. Peaks specifically located at the Lag3 promoters are identified by red rectangles. (I) H3K18la occupancy analysis by ChIP‐qPCR ( n = 3). Data are mean ± SD. Statistical significance was assessed by unpaired 2‐tailed Student t ‐test compared with Con group. **** p < 0.0001.

    Article Snippet: Sur + 2‐DG mice received 2‐DG (250 mg/kg; MedChemExpress, HY‐13966) [ ] intraperitoneally once daily for 2 days preoperatively until 30 min before surgery.

    Techniques: RNA Sequencing, Binding Assay, Genome Wide, ChIP-qPCR

    H3K18la promotes Lag3 expression in microglial cells induced by either lactate or LPS and IFN‐γ. (A) BV2 cells were first treated with 0‐, 1‐, 5‐, and 25‐mM lactate for 24 h. Subsequently, cells pretreated with 25 mM lactate or 10 mM 2‐DG for 3 h were stimulated with LPS and IFN‐γ for 24 h. (B) Representative immunoblotting of Pan‐Kla, H3K18la and Lag3 in BV2 cells intervention with lactate, with histone H3 or GAPDH used for normalization. (C‐E) Quantitation of Pan‐Kla, H3K18la and Lag3 gray value ( n = 3). (F) The lactate levels of BV2 cells activated by LPS and IFN‐γ ( n = 5–6). (G) Representative immunoblotting of Pan‐Kla, H3K18la and Lag3 in BV2 cells activated by LPS and IFN‐γ, with histone H3 or GAPDH used for normalization. (H–J) Quantitation of Pan‐Kla, H3K18la and Lag3 gray value ( n = 3–4). (K) Representative fluorescence images of Pan‐Kla or Lag3 in BV2 cells. (L, M) The relative fluorescence intensities of Pan and Lag3 in BV2 cells ( n = 6). The images include scale indicators of 50 μm for size reference. The data are presented as the mean ± SD, A–D were assessed by unpaired 2‐tailed Student t ‐test compared with Con group. The other results were assessed by one‐way ANOVA followed by Tukey's post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Journal: CNS Neuroscience & Therapeutics

    Article Title: Histone H3K18 Lactylation Contributes to Perioperative Neurocognitive Disorder Through Immune Checkpoint Lymphocyte Activation Gene 3 Mediated Microglial Pyroptosis

    doi: 10.1002/cns.71058

    Figure Lengend Snippet: H3K18la promotes Lag3 expression in microglial cells induced by either lactate or LPS and IFN‐γ. (A) BV2 cells were first treated with 0‐, 1‐, 5‐, and 25‐mM lactate for 24 h. Subsequently, cells pretreated with 25 mM lactate or 10 mM 2‐DG for 3 h were stimulated with LPS and IFN‐γ for 24 h. (B) Representative immunoblotting of Pan‐Kla, H3K18la and Lag3 in BV2 cells intervention with lactate, with histone H3 or GAPDH used for normalization. (C‐E) Quantitation of Pan‐Kla, H3K18la and Lag3 gray value ( n = 3). (F) The lactate levels of BV2 cells activated by LPS and IFN‐γ ( n = 5–6). (G) Representative immunoblotting of Pan‐Kla, H3K18la and Lag3 in BV2 cells activated by LPS and IFN‐γ, with histone H3 or GAPDH used for normalization. (H–J) Quantitation of Pan‐Kla, H3K18la and Lag3 gray value ( n = 3–4). (K) Representative fluorescence images of Pan‐Kla or Lag3 in BV2 cells. (L, M) The relative fluorescence intensities of Pan and Lag3 in BV2 cells ( n = 6). The images include scale indicators of 50 μm for size reference. The data are presented as the mean ± SD, A–D were assessed by unpaired 2‐tailed Student t ‐test compared with Con group. The other results were assessed by one‐way ANOVA followed by Tukey's post hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Article Snippet: Sur + 2‐DG mice received 2‐DG (250 mg/kg; MedChemExpress, HY‐13966) [ ] intraperitoneally once daily for 2 days preoperatively until 30 min before surgery.

    Techniques: Expressing, Western Blot, Quantitation Assay, Fluorescence